Greenwood Capital Associates LLC Sells 26,062 Shares of Apyx Medical Co. (NASDAQ:APYX)

Greenwood Capital Associates LLC cut its stake in shares of Apyx Medical Co. (NASDAQ:APYX) by 10.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 231,758 shares of the company’s stock after selling 26,062 shares during the period. Greenwood Capital Associates LLC’s holdings in Apyx Medical were worth $366,000 as of its most recent SEC filing.

Separately, Private Advisor Group LLC raised its holdings in Apyx Medical by 3.9% in the 3rd quarter. Private Advisor Group LLC now owns 322,321 shares of the company’s stock worth $400,000 after purchasing an additional 12,180 shares during the period. 55.33% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have weighed in on APYX shares. Craig Hallum raised shares of Apyx Medical to a “strong-buy” rating in a report on Thursday, October 24th. BTIG Research began coverage on Apyx Medical in a research report on Thursday, October 17th. They set a “neutral” rating for the company.

Apyx Medical Trading Up 2.5 %

APYX stock opened at $1.46 on Wednesday. The firm’s fifty day simple moving average is $1.58 and its two-hundred day simple moving average is $1.37. The stock has a market capitalization of $54.77 million, a price-to-earnings ratio of -1.75 and a beta of 1.25. The company has a quick ratio of 4.52, a current ratio of 5.46 and a debt-to-equity ratio of 3.03. Apyx Medical Co. has a twelve month low of $0.97 and a twelve month high of $2.80.

Apyx Medical (NASDAQ:APYX) last posted its quarterly earnings data on Friday, November 8th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.01. The company had revenue of $11.49 million during the quarter, compared to analysts’ expectations of $11.66 million. Apyx Medical had a negative return on equity of 137.98% and a negative net margin of 58.59%. During the same quarter in the previous year, the business earned ($0.13) EPS. As a group, analysts anticipate that Apyx Medical Co. will post -0.68 earnings per share for the current year.

Apyx Medical Company Profile

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.